REDUCTION OF FATAL COMPLICATIONS FROM COMBINED MODALITY THERAPY IN HODGKINS-DISEASE

被引：36

作者：

MAUCH, PM

CANELLOS, GP

ROSENTHAL, DS

HELLMAN, S

机构：

[1] BRIGHAM & WOMENS HOSP, JOINT CTR RADIAT THERAPY, DEPT HEMATOL, 50 BINNEY ST, BOSTON, MA 02115 USA

[2] HARVARD UNIV, SCH MED, DEPT RADIAT THERAPY, BOSTON, MA 02115 USA

[3] DANA FARBER CANC INST, BOSTON, MA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1985年 / 3卷 / 04期

关键词：

D O I：

10.1200/JCO.1985.3.4.501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：501 / 505

页数：5

共 35 条

[1]

BACCARANI M, 1980, CANCER, V46, P1735, DOI 10.1002/1097-0142(19801015)46:8<1735::AID-CNCR2820460806>3.0.CO

[2]

2-3

[3]

CANELLOS GP, 1975, LANCET, V1, P947

[4]

COLEMAN CN, 1979, NEW ENGL J MED, V297, P249

[5]

COLTMAN CA, 1982, CANCER TREAT REP, V66, P1023

[6]

CUNNINGHAM J, 1982, CANCER TREAT REP, V66, P1015

[7] COMBINATION CHEMOTHERAPY IN TREATMENT OF ADVANCED HODGKINS DISEASE [J].

DEVITA, VT ;

SERPICK, AA ;

CARBONE, PP .

ANNALS OF INTERNAL MEDICINE, 1970, 73 (06) :881-+

[8]

DONALDSON SS, 1978, CANCER-AM CANCER SOC, V41, P1949, DOI 10.1002/1097-0142(197805)41:5<1949::AID-CNCR2820410539>3.0.CO

[9]

2-K

[10] PERSISTENT IMMUNOLOGICAL ABNORMALITIES IN LONG-TERM SURVIVORS OF ADVANCED HODGKINS-DISEASE [J].

FISHER, RI ;

DEVITA, VT ;

BOSTICK, F ;

VANHAELEN, C ;

HOWSER, DM ;

HUBBARD, SM ;

YOUNG, RC .

ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :595-599

← 1 2 3 4 →